CEACAM5 ANTIBODY-DRUG CONJUGATE FORMULATION

Provided are stabilized formulations of the human carcinoembryonic antigen-related cell adhesion molecule 5 (hCEACAM5)-targeted antibody-drug conjugate huMAb2-3-SPDB-DM4, as well as methods for making and using same. L'invention concerne des formulations stabilisées du conjugué anticorps-médica...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	LEMAN, MARIE, BENSAID, FETHI, AUTHELIN, JEAN-RENE, BONESTEBE, AUDREY, MANACHE-ALBERICI, LUCIE, HUILLE, SYLVAIN
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Provided are stabilized formulations of the human carcinoembryonic antigen-related cell adhesion molecule 5 (hCEACAM5)-targeted antibody-drug conjugate huMAb2-3-SPDB-DM4, as well as methods for making and using same. L'invention concerne des formulations stabilisées du conjugué anticorps-médicament ciblant la molécule d'adhésion cellulaire 5 liée à l'antigène carcinoembryonnaire humain (hCEACAM5), huMAb2-3-SPDB-DM4, ainsi que des procédés de production et d'utilisation de celui-ci.